| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 139133-27-0 | Nupafant | Nupafant Unii-02nki0arrj | ||
| 2 | 2601727-91-5 | 2601727-91-5 | |||
| 3 | 1948273-02-6 | (S,R,S)-AHPC-Me | ZB1468 CPD101077 VHL ligand 2 1948273-02-6 (S,R,S)-AHPC-Me E3 ligase Ligand 1A E3 ligase Ligand 1 (free base) (S,R,S)-AHPC-ME (VHL LIGAND 2)(HYDROCHLORIDE) L-Prolinamide, 3-methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (4R)- (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide (2S,4S)-1-[(2S)-2-amino-3,3-dimethylbutanoyl]-4-h ydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phen yl]ethyl]pyrrolidine-2-carboxamide | ||
| 4 | N-[2-(DIMETHYLAMINO)ETHYL]-N-(1-[2-(METHYLSULFONYL)BENZYL]PIPERIDIN-4-YL)NICOTINAMIDE | N-[2-(DIMETHYLAMINO)ETHYL]-N-(1-[2-(METHYLSULFONYL)BENZYL]PIPERIDIN-4-YL)NICOTINAMIDE | |||
| 5 | N'-ISOPROPYL-N-(1-[2-(METHYLSULFONYL)BENZYL]PIPERIDIN-4-YL)-N-(PYRIDIN-3-YLMETHYL)UREA | N'-ISOPROPYL-N-(1-[2-(METHYLSULFONYL)BENZYL]PIPERIDIN-4-YL)-N-(PYRIDIN-3-YLMETHYL)UREA | |||
| 6 | 8-[3-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]propyloxy]-9-hydroxy-8-azaspiro[4.5]decan-7-one | 8-[3-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]propyloxy]-9-hydroxy-8-azaspiro[4.5]decan-7-one | |||
| 7 | 190582-37-7 | Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- | Perospirone Impurity 17 Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- | ||
| 8 | 2380273-25-4 | (2S,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide | (2S,4S)-1-((S)-2-AMINO-3,3-DIMETHYLBUTANOYL)-4-HYDROXY-N-((S)-1-(4-(4-METHYLTHIAZOL-5-YL)PHENYL)ETHY (2S,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|